On air · 1 of 3 networks
RTW Investments, LP
- rtwfunds.com
- US
- 155 employees
RTW Investments, LP’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 29. Watch RTW Investments, LP with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 29 | Checked 29 Oct 2026 | See all 29 ads → | ||
| Meta | Not checked | — | |||
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 8 Oct 2026 | Collect them with the API → |
RTW Investments, LP has 29 live LinkedIn ads. We recorded no Google ads on 8 Oct 2026.
Latest ads
- LINKEDIN · FOLLOWRecorded 30 Sept 2026
Get the latest jobs and industry news
- LINKEDIN · VIDEORecorded 29 Oct 2026
Rod Wong sees cancer as biotech’s flag bearer for the next decade. Our preview of the upcoming European Society for Medical Oncology (ESMO 2026) follows four types of medicine that are moving from proof of concept toward standard of care and shows how to read the data when it arrives in Madrid, October 23 to 27.
- LINKEDIN · VIDEORecorded 29 Oct 2026
Rod Wong sees cancer as biotech’s flag bearer for the next decade. Our preview of the upcoming European Society for Medical Oncology (ESMO 2026) follows four types of medicine that are moving from proof of concept toward standard of care and shows how to read the data when it arrives in Madrid, October 23 to 27.
- LINKEDIN · VIDEORecorded 29 Oct 2026
Rod Wong sees cancer as biotech’s flag bearer for the next decade. Our preview of the upcoming European Society for Medical Oncology (ESMO 2026) follows four types of medicine that are moving from proof of concept toward standard of care and shows how to read the data when it arrives in Madrid, October 23 to 27.
- LINKEDIN · ARTICLERecorded 9 Oct 2026
American medical care rests on two pillars: innovation and affordability. Weaken either one and patients pay the price, either in the cures that never arrive or in the bills they cannot afford. RTW's Rod Wong argues both pillars are under strain today. Americans are relying on a drug development system that hasn't caught up with new modalities like gene therapy, while facing a health care pricing system with almost no transparency. Read how Rod thinks about both pillars, and the specific reforms he'd prioritize to strengthen them at once. Click on the image to read the full article.
- LINKEDIN · VIDEORecorded 30 Sept 2026
5,000 known genetic diseases could theoretically be treated with gene therapy, says RTW's CIO Rod Wong. But without the right incentives and regulatory flexibility, the technology may never deliver on that promise. Listen to the new episode of the RTW Podcast.
6 of 29 adsSign up to see every RTW Investments, LP ad, filter by format and date, and get alerts on new ones.
See all 29 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.